)
Summit Therapeutics (SMMT) investor relations material
Summit Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Meeting scheduled for June 10, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by June 9, 2026.
Voting matters and shareholder proposals
Election of nine directors is up for shareholder vote.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay) is included.
Proposal to amend the 2020 Stock Incentive Plan to increase the number of shares of common stock.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and all proposals.
Proxy allows discretionary voting on other matters that may arise at the meeting.
- Annual meeting to vote on directors, auditor, executive pay, and stock plan amendment.SMMT
Proxy filing17 Apr 2026 - Ivonescimab advances with FDA BLA, strong cash, and major Phase III milestones ahead.SMMT
Q4 202510 Apr 2026 - Board recommends approval of all proposals, including director elections and stock plan amendment.SMMT
Proxy filing6 Apr 2026 - Ivonescimab demonstrates best-in-class efficacy and broad expansion potential in global oncology.SMMT
The Citizens Life Sciences Conference 202611 Mar 2026 - Ivonescimab advances globally with strong phase III data and key regulatory milestones ahead.SMMT
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Ivonescimab's strong Phase III data drives BLA plans and global trials amid urgent funding needs.SMMT
Q3 202512 Feb 2026 - Ivonescimab outperformed pembrolizumab in NSCLC trials and extended cash runway with $200M raise.SMMT
Q2 20242 Feb 2026 - $200M equity raise, $70M territory deal, and strong PFS/OS data for ivonescimab reported.SMMT
Status Update31 Jan 2026 - Ivonescimab halved progression risk and improved response rates in advanced PD-L1+ NSCLC.SMMT
Study Update21 Jan 2026
Next Summit Therapeutics earnings date
Next Summit Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage